If PREVNAR 20 is administered at the same time as another injectable vaccine, the vaccines should always be administered with different syringes and given at different injection sites.
Do not mix PREVNAR 20 with other vaccines/products in the same syringe.
Adults
PREVNAR 20 can be administered concomitantly with influenza vaccine, adjuvanted quadrivalent (QIV) or with COVID-19 mRNA vaccine (see 14 CLINICAL TRIALS, Concomitant vaccine administration)
Infants and Children 6 Weeks To <5 Years of Age
In infants and children 6 weeks to <5 years of age, PREVNAR 20 can be administered concomitantly with any of the following vaccine antigens, either as monovalent or combination vaccines: diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, inactivated poliomyelitis, hepatitis B, measles, mumps, rubella (MMR) and varicella vaccines. The vaccine has been safely administered with influenza and rotavirus vaccine.
There are no data on the concomitant administration of PREVNAR 20 with other vaccines.
)If PREVNAR 20 is administered at the same time as another injectable vaccine, the vaccines should always be administered with different syringes and given at different injection sites.
Do not mix PREVNAR 20 with other vaccines/products in the same syringe.
Adults
PREVNAR 20 can be administered concomitantly with influenza vaccine, adjuvanted quadrivalent (QIV) or with COVID-19 mRNA vaccine (see 14 CLINICAL TRIALS, Concomitant vaccine administration)
Infants and Children 6 Weeks To <5 Years of Age
In infants and children 6 weeks to <5 years of age, PREVNAR 20 can be administered concomitantly with any of the following vaccine antigens, either as monovalent or combination vaccines: diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, inactivated poliomyelitis, hepatitis B, measles, mumps, rubella (MMR) and varicella vaccines. The vaccine has been safely administered with influenza and rotavirus vaccine.
There are no data on the concomitant administration of PREVNAR 20 with other vaccines.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product:
You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.